会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • VITAMIN-TARGETED IMAGING AGENTS
    • 维生素靶向成像剂
    • WO2003092742A1
    • 2003-11-13
    • PCT/US2003/014379
    • 2003-05-06
    • ENDOCYTE, INC.LEAMON, Christopher, PaulPARKER, Matthew, A.
    • LEAMON, Christopher, PaulPARKER, Matthew, A.
    • A61K49/00
    • A61K51/08A61K47/54A61K47/551A61K51/025A61K51/0402A61K51/0459A61K51/0497A61K51/088
    • The invention relates to compounds and methods for targeting radionuclide-based imaging agents to cells having receptors for a vitamin, or vitamin receptor binding derivative or analog thereof, by using such a vitamin as the targeting ligand for the imaging agent. The invention provides a compound of the formula (I) or (II) for use in such methods. In the compound, V is a vitamin that is a substrate for receptor-mediated transmembrane transport in vivo, or a vitamin receptor binding derivative or analog thereof, L is a divalent linker, R is a side chair of an amino acid of the formula H 2 NCHRCOOH, M is a cation of a radionuclide, n is 1 or 0, K is 1 or 0, and the compound can be in a pharmaceutically acceptable carrier therefor. The vitamin-based compounds can be used to target radionuclides to cells, such as a variety of tumor cell types, for use in diagnostic imaging of the targeted cells.
    • 本发明涉及通过使用这样的维生素作为成像剂的靶向配体,将基于放射性核素的成像剂靶向具有维生素或维生素受体结合衍生物或其类似物的受体的细胞的化合物和方法。 本发明提供了用于这些方法的式(I)或(II)化合物。 在化合物中,V是作为体内受体介导的跨膜转运的底物的维生素或维生素受体结合衍生物或其类似物,L是二价连接基,R是式H2NCHRCOOH的氨基酸的侧椅 M是放射性核素的阳离子,n为1或0,K为1或0,该化合物可以是药学上可接受的载体。 基于维生素的化合物可用于将放射性核素靶向细胞,例如各种肿瘤细胞类型,用于靶向细胞的诊断成像。